Clinical Trials Directory

Trials / Unknown

UnknownNCT03015376

Inherited Susceptible Genes Among Epithelial Ovarian Cancer

Cohort Study on Characters and Distribution of Inherited Susceptible Genes Among Epithelial Ovarian Cancer Patients and Their Relatives in the North of China

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Purpose: To investigate the prevalence of the germline mutations in the BRCA 1/2 and mismatch repair genes in patients with epithelial ovarian cancer (EOC) and their relatives, and related somatic mutations in tumor tissues in the northern part of china. Patients and methods: A multicenter prospective study will be hold in the northern part of china form 2017. About 1000 female patients with epithelial ovarian cancer and their ralatives will be tested for germline mutations in the BRCA 1/2 and mismatch repair genes and related somatic mutations in tumor tissues, regardless of the family history. Study type: Observational Official title: Prevalence study of germline mutations in susceptibility ovarian cancer genes in patients with epithelial ovarian cancer and somatic mutations in their tumor tissures in the northern part of china. Enrollment: 1000

Conditions

Timeline

Start date
2017-01-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2017-01-10
Last updated
2018-11-14

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03015376. Inclusion in this directory is not an endorsement.

Inherited Susceptible Genes Among Epithelial Ovarian Cancer (NCT03015376) · Clinical Trials Directory